Pohlman T H, Stanness K A, Beatty P G, Ochs H D, Harlan J M
J Immunol. 1986 Jun 15;136(12):4548-53.
We examined the role of the neutrophil membrane antigen complex designated CDw18 (LFA-1/Mac-1/p150, 95) in human peripheral blood neutrophil adherence to cultured human umbilical vein endothelial cells (HEC) pretreated with lipopolysaccharide (LPS), interleukin 1 (IL 1), or recombinant tumor necrosis factor-alpha (rTNF-alpha). Pretreatment of HEC with LPS produced a dose-and time-dependent increase in subsequent neutrophil adherence (7 +/- 1% adherence to untreated HEC vs 38 +/- 3% adherence to HEC pretreated for 4 hr with LPS 150 ng/ml; mean +/- SE of 22 experiments: p less than 0.001). This effect was observed in primary and passaged HEC, but not in bovine aortic endothelial cells or human dermal fibroblasts. The LPS-induced activity appeared to be associated with the HEC surface, since it was not removed by washing and was not detected in the supernatant medium. Inhibition of RNA or protein synthesis during pretreatment of HEC with LPS prevented induction of the adherence-promoting activity. Pretreatment of HEC with IL 1 and rTNF-alpha produced a similar protein synthesis-dependent increase in neutrophil adherence to HEC. Coincubation of neutrophils with murine monoclonal antibody (MoAb) 60.3, an antibody directed to the CDw18 complex, produced a 70 +/- 4% inhibition of neutrophil adherence to LPS-pretreated HEC, 59 +/- 5% inhibition of adherence to IL 1-pretreated HEC, and 65 +/- 11% inhibition of adherence to rTNF-alpha-pretreated HEC (means +/- SE of 18, seven, and five experiments, respectively). Notably, MoAb 60.3 did not completely inhibit neutrophil adherence to pretreated HEC, although it completely inhibited adherence to untreated HEC when neutrophils were activated directly with phorbol ester. Similarly, the adherence of neutrophils from a patient with an inherited deficiency of the CDw18 complex to LPS-, IL 1-, and rTNF-alpha-pretreated HEC was markedly reduced compared with normal neutrophils (5 to 11% adherence with CDw18-deficient neutrophils vs 43 to 54% adherence with normal neutrophils), but adherence to pretreated HEC was still significantly greater than adherence to HEC that were not pretreated (2% adherence). We conclude that LPS, IL 1, and rTNF-alpha induce synthesis of an endothelial cell-surface factor(s) that promotes neutrophil adherence primarily by a mechanism involving the CDw18 complex. It thus appears that the CDw18 complex is important for augmented neutrophil adherence to endothelium in vitro whether the is stimulated directly by inflammatory mediators or indirectly by endothelial-dependent mechanisms.
我们研究了名为CDw18(淋巴细胞功能相关抗原-1/巨噬细胞抗原-1/p150,95)的中性粒细胞膜抗原复合物在人外周血中性粒细胞黏附于经脂多糖(LPS)、白细胞介素1(IL-1)或重组肿瘤坏死因子-α(rTNF-α)预处理的人脐静脉内皮细胞(HEC)过程中的作用。用LPS预处理HEC会导致随后中性粒细胞黏附呈剂量和时间依赖性增加(未处理的HEC黏附率为7±1%,而用150 ng/ml LPS预处理4小时的HEC黏附率为38±3%;22次实验的平均值±标准误:p<0.001)。在原代和传代的HEC中均观察到这种效应,但在牛主动脉内皮细胞或人皮肤成纤维细胞中未观察到。LPS诱导的活性似乎与HEC表面相关,因为通过洗涤不能去除该活性,且在上清培养基中未检测到。在用LPS预处理HEC期间抑制RNA或蛋白质合成可阻止黏附促进活性的诱导。用IL-1和rTNF-α预处理HEC也会使中性粒细胞对HEC的黏附产生类似的蛋白质合成依赖性增加。将中性粒细胞与针对CDw18复合物的鼠单克隆抗体(MoAb)60.3共同孵育,可使中性粒细胞对LPS预处理的HEC的黏附抑制70±4%,对IL-1预处理的HEC的黏附抑制59±5%,对rTNF-α预处理的HEC的黏附抑制65±11%(分别为18次、7次和5次实验的平均值±标准误)。值得注意的是,MoAb 60.3并未完全抑制中性粒细胞对预处理的HEC的黏附,尽管当用佛波酯直接激活中性粒细胞时,它能完全抑制对未处理的HEC的黏附。同样,与正常中性粒细胞相比,一名患有CDw18复合物遗传性缺陷的患者的中性粒细胞对LPS、IL-1和rTNF-α预处理的HEC的黏附明显降低(CDw18缺陷的中性粒细胞黏附率为5%至11%,而正常中性粒细胞黏附率为43%至54%),但对预处理的HEC的黏附仍显著高于对未预处理的HEC的黏附(黏附率为2%)。我们得出结论,LPS、IL-1和rTNF-α诱导合成一种内皮细胞表面因子,该因子主要通过涉及CDw18复合物的机制促进中性粒细胞黏附。因此,无论炎症介质是直接刺激还是通过内皮依赖性机制间接刺激,CDw18复合物对于体外增强中性粒细胞对内皮的黏附似乎都很重要。